The global anti-infectives market size was US$ 117.54 billion in 2021. The global anti-infectives market is forecast to grow to US$ 209.25 billion by 2030 by growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2022 to 2030.

Factors Influencing the Market

Anti-infective drugs are deployed to kill the micro-organism present inside the body. The growing prevalence of diseases caused due to microorganisms is forecast to fuel the growth of the global anti-infectives market.

The launch of new effective drugs and the rising number of vaccine approvals are forecast to benefit the global anti-infectives market during the study period.

The growing number of hospitals and primary care clinics globally will contribute to the growth of the market. On the contrary, the high cost of drugs may restrict the growth of the market during the study period.

The high spending of consumers on healthcare will surge the growth of the market. In addition, favorable policies from governments to offer incentives and cost-efficient treatment to the patients is likely to benefit the global anti-infectives market.

COVID-19 Impact Analysis

The COVID-19 pandemic has been beneficial for the anti-infectives market. The demand for anti-infectives emerged strongly after the wake of the pandemic. Many governments healthcare centers started offering free treatment to patients. As a result, the demand for anti-infectives surged inevitably. The demand for the anti-infectives market is forecast to steeply even after the pandemic. It is due to the growing awareness related to health and hygiene. Thus, it will contribute to the growth of the anti-infectives market.

Regional Analysis

North America is forecast to dominate the anti-infectives market in terms of revenue. The growth of the market is attributed to the high healthcare expenditure and rising consumer spending on healthcare. The demand for anti-infectives is increasing in the region due to the contribution of the prominent players in the region. Furthermore, the growing awareness amongst the consumers related to healthcare will escalate the growth of the market. Governments in the region are investing highly in boosting the healthcare infrastructure, which is also driving the growth of the market.

Competitors in the Market

Abbott Laboratories Limited
Cipla Ltd.
Claris Life Sciences Ltd.
Glenmark Pharmaceuticals Ltd.
GlaxoSmithKline Pharmaceuticals Ltd.
Lupin Ltd.
Panacea Biotech Ltd.
Novartis AG
Pfizer Ltd.
Ranbaxy Laboratories Ltd.
Sun Pharmaceuticals Ltd.
Other Prominent Players
Market Segmentation

The global anti-infectives market segmentation focuses on Product, Indication, Distribution Channel, Administration, Range, End-User, and Region.

Based on product, the anti-infectives market has been segmented into

Antibiotics
Antivirals
Antifungals
Others
Based on indication, the anti-infectives market has been segmented into-

HIV Infection
Pneumonia
Respiratory Virus Infection
Sepsis
Tuberculosis
Others
Based on distribution channel, the anti-infectives market has been segmented into-

Hospital Pharmacy
Retail Pharmacy
Others
Based on route of administration, the anti-infectives market has been segmented into-

Oral
Topical
Parenteral
Others
Based on range, the anti-infectives market has been segmented into-

Narrow Spectrum
Broad Spectrum
Based on end-users, the anti-infectives market has been segmented into-

Hospitals
Homecare
Specialty Clinics
Others
Based on region, the anti-infectives market has been segmented into-

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America